Synapse - Kelsey Alvarez

Kelsey Alvarez

Groups

Nursing

Research Focus

Former Employee. David H . Koch Center; Clinical Nurse III

https://orcid.org/0000-0001-8819-4572

18801

Recent additions – View all

Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: A single-centre, single-arm, phase 2 trial
Journal Article

Taylor, J.; Mi, X.; Penson, A. V.; Paffenholz, S. V.; Alvarez, K.; Sigler, A.; Chung, S. S.; Rampal, R. K.; Park, J. H.; Stein, E. M.; more...
The Lancet Haematology (2020)

Fulltext@MSK | Save
Safety and efficacy of combined ruxolitinib and thalidomide in patients with myelofibrosis: A phase II study
Meeting Abstract

Rampal, R. K.; Verstovsek, S.; Devlin, S. M.; King, A. C.; Stein, E. M.; Pemmaraju, N.; Mauro, M. J.; Kadia, T. M.; Montalban-Bravo, G.; Alvarez, K.; more...
Blood (2019)

Fulltext@MSK | Save
Selinexor, a first-in-class XPO1 inhibitor, is efficacious and tolerable in patients with myelodysplastic syndromes refractory to hypomethylating agents
Meeting Abstract

Taylor, J.; Coleman, M.; Alvarez, K.; Pichardo, J.; Sen, F.; Chung, S. S.; Rampal, R. K.; Park, J. H.; Stein, E. M.; Tallman, M. S.; more...
Blood (2018)

Fulltext@MSK | Save

Co-authors at MSK

4

Rampal
3

Klimek
3

Sen
2

Abdel-W...
2

Chung
2

Coleman
2

Devlin
2

Goodman
2

Mauro
2

Park
2

Pichardo
2

Stein
2

Tallman
2

Taylor
1

Gonen
1

King
1

Mi
1

Paffenholz
1

Penson
1

Sigler

Types of Work

Publications